BYSI
BeyondSpring Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.73
+2.95%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-55.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | Qiu Min · officer: Chief Executive Officer | A-Award | 100,000 | $1.75 |
| Jul 6, 2026 | Majeti Jiangwen · director | A-Award | 100,000 | $1.75 |
| Apr 8, 2026 | Kirkby Matthew · director | A-Award | 23,902 | $1.64 |
| Apr 3, 2026 | Fabbio Patrick · director | A-Award | 22,165 | $1.64 |
| Apr 3, 2026 | Majeti Jiangwen · director | A-Award | 21,730 | $1.64 |
| Apr 3, 2026 | Delaney Brendan · director | A-Award | 20,427 | $1.64 |
| Apr 3, 2026 | Lu Yingjuan June · officer: Chief Scientific Officer | A-Award | 17,840 | $1.64 |
| Apr 3, 2026 | Huang Lan · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 11,514 | $1.80 |
| Apr 3, 2026 | Xu Sihai · director | A-Award | 18,689 | $1.64 |
| Oct 20, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 45,513 | $1.76 |
| Oct 20, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 85,798 | $1.72 |
| Oct 15, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 17,960 | $1.65 |
| Oct 15, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 107,361 | $1.70 |
| Oct 15, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 28,495 | $1.65 |
| Oct 10, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 7,507 | $1.77 |
| Oct 10, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 3,979 | $1.81 |
| Oct 10, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 2,390 | $1.77 |
| Oct 7, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 600 | $1.76 |
| Oct 7, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 2,100 | $1.79 |
| Oct 7, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 17,500 | $1.78 |
| Oct 2, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 600 | $1.73 |
| Oct 2, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 4,464 | $1.81 |
| Oct 2, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 2,601 | $1.80 |
| Sep 29, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 700 | $1.66 |
| Sep 29, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 500 | $1.75 |
| Sep 29, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 600 | $1.68 |
| Sep 24, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 5,410 | $1.83 |
| Sep 24, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 4,106 | $1.72 |
| Sep 24, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 2,256 | $1.68 |
| Sep 19, 2025 | Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent owner | Sale | 2,304 | $1.83 |
Institutional positioning
13F filings over the trailing two quarters
New 10Increased 11Reduced 8Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DECHENG CAPITAL LLC | Unchanged | 3,800,702 | May 13, 2026 |
| Decheng Capital LLC | Unchanged | 3,800,702 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 672,915 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 649,462 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 626,457 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 607,934 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 375,371 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 367,740 | Aug 12, 2026 |
| STATE STREET CORP | Unchanged | 231,120 | May 15, 2026 |
| STATE STREET CORP | Unchanged | 231,120 | Aug 7, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 181,196 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 179,925 | May 8, 2026 |
| NORTHERN TRUST CORP | Unchanged | 69,268 | May 14, 2026 |
| UBS Group AG | Increased | 63,032 | Aug 13, 2026 |
| NORTHERN TRUST CORP | Reduced | 62,024 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 6, 2026